Vinci S.A. Stock
€111.35
Your prediction
Financial data and news for Vinci
sharewise wants to provide you with the best news and tools for Vinci, so we directly link to the best financial data sources.
Financials
News
Intuitive Surgical Stock Has 20% Upside, According to 1 Wall Street Analyst. Is the Stock a Buy Near Its All-Time High?
When it comes to robotic-assisted surgery, no one holds a candle to Intuitive Surgical (NASDAQ: ISRG), a technological leader and pioneer in the field. The company's da Vinci platform is the gold
2 Healthcare Artificial Intelligence (AI) Stocks That Could Be Smart Investment Bets
Artificial intelligence (AI) has been the hottest investing trend since early 2023. That's not surprising, because AI could change how many companies do business while making the industry's leaders
Is Intuitive Surgical Stock a Millionaire Maker?
Intuitive Surgical (NASDAQ: ISRG) is a healthcare company with the potential to help transform an industry with its robotic-assisted surgical systems. By making surgeries easier and more precise for
1 New Reason to Buy Intuitive Surgical Stock and Hold Forever
Intuitive Surgical (NASDAQ: ISRG) has quite a few traits that make it a desirable stock to buy and hold for long periods. Aside from being a leader in the robotic surgery space, it's consistently
Adding $1,000 to These Top Growth Stocks Would Be a Brilliant Move
Looking for great stocks to buy in a bull market has its downsides. For instance, it's harder to find deep discounts during a bull run. However, that's not a big problem provided investors put their
2 Healthcare Growth Stocks That Are No-Brainer Buys Right Now
The healthcare industry has remained a remarkably resilient place for investors to build wealth over the years. Like any industry, this one carries risk for investors to be aware of, too. Regulatory
2 Superior Growth Stocks That Could Go Parabolic
Not all growth stocks are created equal. However, great businesses that deliver products and/or services with durable uses for their target consumers and have a compelling runway ahead can deliver
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
Regardless of the ups and downs of the stock market, companies with innovative businesses driving change in their respective industries present compelling opportunities for investors. If you're on
1 Top AI and Robotics Stock Closed Out 2023 With a Bang -- Is It a Buy for 2024?
Despite ongoing concerns about a rich valuation, shares of healthcare robotics and artificial intelligence (AI) stock Intuitive Surgical (NASDAQ: ISRG) had a stellar 2023. In fact, management just
2 Time-Tested Stocks to Buy Right Now That Could Make You Richer in 2024
Bear markets and volatility are not what investors dream of, but they are a reality if you stay invested in the market for the long term. Over time, the market has a track record of steadily rising
Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying?
It's a bit of a harrowing time to be in the business of selling solutions for bariatric surgery. Thanks to Novo Nordisk's drugs like Ozempic and Wegovy for type 2 diabetes and obesity, and competing
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
Look up the word "revolutionary." Regardless of which dictionary you consult, you're probably going to find a definition along the lines of "causing a major change."
As is the case with other bold
Intuitive Surgical Leads the Robotic Surgery Movement
While artificial intelligence (AI) and robots are in the spotlight regularly these days, there's a company that's been making surgical robots for over two decades. Intuitive Surgical Inc. (NASDAQ:
Intuitive Surgical’s post-earnings dip is a healthy time to buy
Intuitive Surgical (NASDAQ: ISRG) share prices surged following the Q4 release but failed to hold the gain, creating an ugly candle capping a strong rally. The market may move lower from here, but
MarketBeat ‘Stock of the Week’: Intuitive Surgical hits new highs
In the fall of 2023, Intuitive Surgical, Inc. (NASDAQ: ISRG) was among a group of health care provider and food manufacturer stocks crushed by Ozempic fears. The prevailing mindset was that rising